Kato, S., Takai, M., Iinuma, K., Fujimoto, S., Nakano, M., Ishida, T., . . . Koie, T. Sequential Docetaxel in ≥7 Cycles Followed by Cabazitaxel Improves Oncological Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. Wiley.
Chicago Style (17th ed.) CitationKato, Seiichi, et al. Sequential Docetaxel in ≥7 Cycles Followed by Cabazitaxel Improves Oncological Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. Wiley.
MLA (9th ed.) CitationKato, Seiichi, et al. Sequential Docetaxel in ≥7 Cycles Followed by Cabazitaxel Improves Oncological Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. Wiley.
Warning: These citations may not always be 100% accurate.